Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes.

Freemantle N, Blonde L, Duhot D, Hompesch M, Eggertsen R, Hobbs FD, Martinez L, Ross S, Bolinder B, Stridde E.

Diabetes Care. 2005 Feb;28(2):427-8. No abstract available.

PMID:
15677807
2.

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

Ann Intern Med. 2005 Oct 18;143(8):549-58.

PMID:
16230721
3.

The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.

Del Prato S, Blonde L, Martinez L, Göke B, Woo V, Millward A, Gomis R, Canovatchel B, Strack T, Lawrence D, Freemantle N; EXPERIENCE Trial Team..

Diabet Med. 2008 Jun;25(6):662-70. doi: 10.1111/j.1464-5491.2008.02438.x. Epub 2008 Apr 23.

PMID:
18435781
4.

Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

Chancellor J, Aballéa S, Lawrence A, Sheldon R, Cure S, Plun-Favreau J, Marchant N.

Pharmacoeconomics. 2008;26(3):217-34.

PMID:
18282016
5.

Inhaled insulin for diabetes mellitus.

McMahon GT, Arky RA.

N Engl J Med. 2007 Feb 1;356(5):497-502. Review. No abstract available.

PMID:
17267909
6.

Summaries for patients. Inhaled insulin with or instead of oral medications for type 2 diabetes.

[No authors listed]

Ann Intern Med. 2005 Oct 18;143(8):I28. No abstract available.

PMID:
16230717
7.

Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.

Rave K, Heise T, Pfützner A, Boss AH.

Diabetes Care. 2007 Sep;30(9):2307-8. Epub 2007 Jun 22. No abstract available.

PMID:
17586744
8.

Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

Ceglia L, Lau J, Pittas AG.

Ann Intern Med. 2006 Nov 7;145(9):665-75.

PMID:
17088580
9.

[Performance of real-world studies for inhaled insulin].

Göke B.

Dtsch Med Wochenschr. 2005 Jul 8;130 Suppl 2:S91-4. Review. German. No abstract available.

PMID:
15988676
10.

Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy.

Lopez CA, Kanna B.

Arch Intern Med. 2008 Mar 10;168(5):548. doi: 10.1001/archinte.168.5.548. No abstract available.

PMID:
18332304
12.

Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.

Mathieu C.

Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):779-91.

PMID:
17014394
13.

Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.

Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T.

Diabetes Obes Metab. 2006 Sep;8(5):574-80.

PMID:
16918593
14.

Type 2 diabetes mellitus--guidelines for initiating insulin therapy.

Yeap BB.

Aust Fam Physician. 2007 Jul;36(7):549-53.

15.

Overcoming barriers to insulin replacement.

Kuritzky L.

J Fam Pract. 2009 Aug;58(8 Suppl):S25-31. Review. No abstract available.

PMID:
19679028
16.
17.

Inhaled human insulin.

Strack TR.

Drugs Today (Barc). 2006 Apr;42(4):207-21. Review.

PMID:
16703118
18.

First inhaled insulin product approved.

[No authors listed]

FDA Consum. 2006 Mar-Apr;40(2):28-9.

19.

Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.

Reimer T, Hohberg C, Pfützner AH, Jørgensen C, Jensen KH, Pfützner A.

Clin Ther. 2008 Dec;30(12):2252-62. doi: 10.1016/j.clinthera.2008.12.004.

PMID:
19167585
20.

Supplemental Content

Support Center